Distinguished in Spastic Ataxia Charlevoix-Saguenay Type

Matthis Synofzik

Otfried Müller Str. 23, 
Tuebingen, BW, DE 
Distinguished in Spastic Ataxia Charlevoix-Saguenay Type
Otfried Müller Str. 23, 
Tuebingen, BW, DE 
OverviewLocationsClinical Research

Overview

Matthis Synofzik practices in Tuebingen, Germany. Mr. Synofzik is rated as a Distinguished expert by MediFind in the treatment of Spastic Ataxia Charlevoix-Saguenay Type. His top areas of expertise are Drug Induced Dyskinesia, Frontotemporal Dementia, Acute Cerebellar Ataxia, Spinocerebellar Ataxia, and Deep Brain Stimulation.

His clinical research consists of co-authoring 487 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 13 articles in the study of Spastic Ataxia Charlevoix-Saguenay Type.

Gender
Male

Locations

Otfried Müller Str. 23, Tuebingen, BW 72076, Germany
Other Locations
Hoppe Seyler Str. 3, Tuebingen, BW 72076, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1, Blinded, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of BIIB132 Administered Intrathecally to Adults With Spinocerebellar Ataxia 3
A Phase 1, Blinded, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of BIIB132 Administered Intrathecally to Adults With Spinocerebellar Ataxia 3
Enrollment Status: Terminated
Publish Date: August 04, 2023
Intervention Type: Drug
Study Drug: BIIB132
Study Phase: Phase 1

476 Total Publications

Cerebrovascular Reactivity at Rest and Its Association With Cognitive Function in People With Genetic Frontotemporal Dementia.
Cerebrovascular Reactivity at Rest and Its Association With Cognitive Function in People With Genetic Frontotemporal Dementia.
Journal: Neurology
Published: September 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Synofzik's expertise for a condition
ConditionClose
View All 15 Elite Conditions
View All 14 Distinguished Conditions
View All 22 Advanced Conditions
View All 63 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile